Anesthesiology Doctors in Cedar Rapids, IA Accepting Medicare

4 Anesthesiology doctors found. Showing 1 - 4

Dr. David Brent Carter, D.O., PHARMD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1026 A Ave Ne, Cedar Rapids, IA 52402 Phone: 319-369-7000

Mary C Kemen, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1026 A Ave Ne, Suite 5000, Cedar Rapids, IA 52402 Phone: 319-368-5976    Fax: 319-368-5800

Michael Baker, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1026 A Ave Ne, Cedar Rapids, IA 52402 Phone: 319-743-7300    Fax: 319-743-7311

Dr. Bradley Hampton Wheeler, DO Anesthesiology Medicare: Medicare Enrolled Practice Location: 701 10th St Se, Cedar Rapids, IA 52403 Phone: 319-398-6011

News Archive

Schering-Plough has reached an agreement with the U.S. Securities and Exchange Commission

Schering-Plough Corporation today reported that it has reached an agreement with the U.S. Securities and Exchange Commission (SEC) to settle issues related to compliance with the books and records and internal accounting control provisions of the U.S. Foreign Corrupt Practices Act by a Schering-Plough subsidiary in Poland.

Researchers develop a model to test which methods are effective at reducing COVID-19 spread

Simon Fraser University professors Paul Tupper and Caroline Colijn have found that physical distancing is universally effective at reducing the spread of COVID-19, while social bubbles and masks are more situation-dependent.

Researchers develop unique, biofuel-powered sensor to prevent and diagnose diseases

Researchers at Washington State University have developed an implantable, biofuel-powered sensor that runs on sugar and can monitor a body's biological signals to detect, prevent and diagnose diseases.

Alcon increases its financial support for NovaBay Pharmaceuticals' research and development efforts

NovaBay Pharmaceuticals, Inc., a clinical stage biopharmaceutical company creating a new class of anti-infectives for treating multi-drug resistant pathogens, announced today that effective immediately, its partner, Alcon Inc. has increased its on-going financial support of the company's research and development efforts by more than $2 million per year. The additional funding is expected to enhance NovaBay's pre-clinical and clinical development programs in the areas of eye, ear and sinus infections, as well as contact lens solutions.

British biotech calls for faster regulatory process to tackle AMR threat

Representing small and medium-sized companies, Ian Staples, Chief Executive of British biotech Matoke Holdings, called on the House of Lords Science and Technology Committee to help ensure that life-saving drugs can get through the regulatory process faster. The Committee was taking evidence as part of its ‘Life Sciences and the Industrial Strategy' inquiry.

Read more Medical News

› Verified 6 days ago